title: Metabolic engineering and in vitro biosynthesis of phytochemicals and non-natural analogues.
abstract: Over the years, natural products from plants and their non-natural derivatives have shown to be active against different types of chronic diseases. However, isolation of such natural products can be limited due to their low bioavailability, and environmental restrictions. To address these issues, in vivo and in vitro reconstruction of plant metabolic pathways and the metabolic engineering of microbes and plants have been used to generate libraries of compounds. Significant advances have been made through metabolic engineering of microbes and plant cells to generate a variety of compounds (e.g. isoprenoids, flavonoids, or stilbenes) using a diverse array of methods to optimize these processes (e.g. host selection, operational variables, precursor selection, gene modifications). These approaches have been used also to generate non-natural analogues with different bioactivities. In vitro biosynthesis allows the synthesis of intermediates as well as final products avoiding post-translational limitations. Moreover, this strategy allows the use of substrates and the production of metabolites that could be toxic for cells, or expand the biosynthesis into non-conventional media (e.g. organic solvents, supercritical fluids). A perspective is also provided on the challenges for generating novel chemical structures and the potential of combining metabolic engineering and in vitro biocatalysis to produce metabolites with more potent biological activities.
authors.affiliation: Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies (CBIS), Rensselaer Polytechnic Institute, 110 8th Street, Troy, NY 12180, United States.
authors.forename: Mauricio
authors.initials: M
authors.lastname: Mora-Pale
authors.forename: Sandra P
authors.initials: SP
authors.lastname: Sanchez-Rodriguez
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Linhardt
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Dordick
authors.forename: Mattheos A G
authors.initials: MA
authors.lastname: Koffas
mesh_terms: D000470:Alkaloids / Q000737:chemistry / Q000378:metabolism; D001688:Biological Products / Q000737:chemistry / Q000378:metabolism; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism*; D005419:Flavonoids / Q000378:metabolism; D015870:Gene Expression; D060847:Metabolic Engineering; D053858:Metabolic Networks and Pathways; D064209:Phytochemicals / Q000737:chemistry / Q000378:metabolism*; D059828:Plant Cells / Q000737:chemistry / Q000378:metabolism; D010944:Plants / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000378:metabolism*; D013267:Stilbenes / Q000737:chemistry / Q000378:metabolism; D058615:Synthetic Biology; D013729:Terpenes / Q000737:chemistry / Q000378:metabolism
chemical_list: D000470:Alkaloids; D001688:Biological Products; D005419:Flavonoids; D064209:Phytochemicals; D013267:Stilbenes; D013729:Terpenes
keywords: Alkaloids; Flavonoids; Metabolic engineering; Phytochemicals; Recombinant microogranisms; Synthetic biology; Terpenoids